11th Annual Workshop on Advanced Clinical Care - AIDS (AWACC), Durban, South Africa, 6-7 Sep 2017


The workshop is targeted at 400 clinicians, clinical virologists and nurses working in the public sector who are currently involved in the treatment of patients with HIV and TB in KwaZulu-Natal, South Africa.

This annual workshop attracts clinicians (nurses and doctors and pharmacists) from the private sector and public sector.

Krisp, the Southern African Treatment and Resistance Network (SATuRN) in partnership with CAPRISA ACC will present a full day programme on HIV & TB Drug Resistance and Clinical Management.

Organising Committee

Dr Henry Sunpath (chairperson) KZN Department of Health and University of KwaZulu-Natal, South Africa

Prof. Raj Gandhi Mass General Hospital (MGH), Harvard Medical School, U.S.A.

Prof. Yunus Moosa University of KwaZulu-Natal, South Africa

Prof. Tulio de Oliveira SATuRN & Nelson R Mandela School of Medicine, UKZN, Durban, South Africa


Speakers

Dr. M. Archary University of KwaZulu-Natal, South Africa

Prof. K. Ard Harvard Medical School, U.S.A.

Prof. Linda G. Bekker University of Cape Town, South Africa

Dr. Francesca Conradie WHRI, South Africa

Prof. Tulio de Oliveira SATuRN & Nelson R Mandela School of Medicine, UKZN, Durban, South Africa

Prof. Raj Gandhi Mass General Hospital (MGH), Harvard Medical School, U.S.A.

Prof. R. Goldstein Harvard Medical School, U.S.A.

Dr. Richard Lessells London School of Hygiene and Tropical Medicine, U.K.

Prof. V.C. Marconi Emory University, U.S.A

Prof. I. Master Department of Health and King George V Hospital, South Africa

Prof. S. Mukerji Harvard Medical School, U.S.A.

Dr. Z. Mthembu DREAMS program and MatCH, South Africa

Prof. R. Murphy University of California Los Angeles, U.S.A.

Dr. Kogie Naidoo CAPRISA, South Africa

Prof. Catherine Orrell University of Cape Town, South Africa

Dr. Nesri Padayatchi CAPRISA, South Africa

Prof. M. Siedner Harvard Medical School, U.S.A.

Prof. Francois Venter WHRI, South Africa


One of the main objectives of Krisp, AWACC SATuRN and CAPRISA is to support the NDoH and build capacity among clinicians to manage patients who still present in advanced HIV and TB clinical disease. In addition, we aim to build capacity as part of the CAPRISA ACC to manage patients who fail virologically and those who may need third line ART.

More information on the joint conference, please visit the website below

News date: 2017-09-06

Links:

http://www.awacc.org